Cart
sales@molnova.com
Home - Products - Others - Other Targets - 4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide

4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide

CAS No. 2163817-03-4

4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide( —— )

Catalog No. M28421 CAS No. 2163817-03-4

4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 78 Get Quote
5MG 124 Get Quote
10MG 178 Get Quote
25MG 318 Get Quote
50MG 474 Get Quote
100MG 686 Get Quote
500MG 1431 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide
  • Note
    Research use only, not for human use.
  • Brief Description
    4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide is a chemical compound.
  • Description
    4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PI3Kδ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2163817-03-4
  • Formula Weight
    409.054
  • Molecular Formula
    C10H7Br2N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NS(=O)(=O)c1ccc(cc1)-n1ncc(Br)c(Br)c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Down K, et al. Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode. J Med Chem. 2021 Sep 23;64(18):13780-13792.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Furilazole

    Furilazole is a herbicide.

  • Cinaciguat

    Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.

  • Cimifugin beta-D-glu...

    Prim-O-glucosylcimifugin can inhibit the proliferation of SMC(smooth muscle cell) stimulated by TNF-alpha, increase the proportion of G0/G1 phase.

Sign In Join Free